HUMIRA (adalimumab), Abbott Laboratories - Package Insert
Real-world effectiveness and safety of adalimumab for treatment of ankylosing spondylitis in Japan
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results - Gastroenterology
Humira, INN - adalimumab
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III - Ophthalmology
Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet's disease: results from a large real-world observational study
Crohn's Remission and Results With HUMIRA® (adalimumab)
Adalimumab: a review of the reference product and biosimilars | BS
Humira, INN - adalimumab
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial - The Lancet Gastroenterology & Hepatology
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis - Gastroenterology
Pre-Clinical Study | Amgevita In Vitro Studies | Amgen
HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data
HUMIRA (adalimumab) Dermatology HCP Site
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis | NEJM
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial - ScienceDirect
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study | Annals of the Rheumatic Diseases
JPM | Free Full-Text | Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis | HTML
AbbVie Move Against Data Transparency | Reuters Events | Pharma
Long-Term Safety of Adalimumab (HUMIRA) in Adult Patients from Global Clinical Trials across Multiple Indications: An Updated Analysis in 29,987 Patients Representing 56,951 Patient-Years - ACR Meeting Abstracts
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial | Annals of the Rheumatic Diseases
Crohn's Remission and Results With HUMIRA® (adalimumab)
A randomised double-blind placebo-controlled crossover trial of HUMira ( adalimumab) for erosive hand OsteoaRthritis – the HUMOR trial - Osteoarthritis and Cartilage
HUMIRA® (adalimumab) for Rheumatoid Arthritis (RA)
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - Gastroenterology
